Skip to main content
Log in

BTXA Could Induce Fibroblast Apoptosis and Inhibit the Expression of α-SMA and Myosin II in Scar Tissue of Rabbit Ears

  • Research Paper
  • Published:
Biotechnology and Bioprocess Engineering Aims and scope Submit manuscript

Abstract

Purpose This study aims to explore the effects of BTXA on the proteins that affect the contraction of fibroblasts. Moreover, the optimal dose of BTXA on hypertrophic scars has not yet been determined. The current study investigated the effect of different doses of BTXA on scar formation. Materials and Methods 18 rabbits’ ears of New Zealand rabbits were used to establish hypertrophic scar model. These wounds were divided into four groups as group B (treated with deferent dosage of BTXA), group T (treated with TAC), group S (not treated), and group C (normal skin). Fibroblast apoptosis was detected by the method of TUNEL. Collagen I, III, and TGF-β1 expression were examined by western blotting method. The immunohistochemical staining and computerized image analysis were used to measure the optical density (OD value) of positive staining of α-SMA and myosin II. Results With increasing BTXA dose, the apoptotic rates increased. Western blot showed that Collagen fibrils and TGF-β1 proteins were expressed lower with the increasing of dose of BTXA (P < 0.05). α-SMA and myosin II in Group B were significantly decreased than those in Group T (P < 0.05), moreover, more myosin II can be reduced with high concentrations of BTXA (2.0 IU). Conclusions It was shown that BTXA could induce fibroblast apoptosis and inhibit the expression of α-SMA and myosin II, which can inhibit FB contraction. It plays a positive role in the treatment of scar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gassner, H. G., D. A. Sherris, and C. C. Otley (2000) Treatment of facial wounds with botulinum toxin a improves cosmetic outcome in primates. Plast. Reconstr. Surg. 105: 1948–1953.

    Article  CAS  Google Scholar 

  2. Liu, Y., B. Deng, Y. Zhao, S. Xie, and R. Nie (2013) Differentiated markers in undifferentiated cells: expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells. Dev. Growth. Differ. 55: 591–605.

    Article  CAS  Google Scholar 

  3. Hallett, M. (1999) One man’s poison—clinical applications of botulinum toxin. N. Engl. J. Med. 341: 118–120.

    Article  CAS  Google Scholar 

  4. Jun, J. Y., J. H. Park, C. S. Youn, and J. H. Lee (2018) Intradermal injection of botulinum toxin: a safer treatment modality for forehead wrinkles. Ann. Dermatol. 30: 458–461.

    Article  Google Scholar 

  5. Polak, F., R. Morton, C. Ward, W. A. Wallace, L. Doderlein, and A. Siebel (2002) Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev. Med. Child. Neurol. 44: 551–555.

    Article  Google Scholar 

  6. Sherris, D. A. and H. G. Gassner (2002) Botulinum toxin to minimize facial scarring. Facial. Plast. Surg. 18: 35–39.

    Article  Google Scholar 

  7. Tracy, L. E., R. A. Minasian, and E. J. Caterson (2016) Extracellular matrix and dermal fibroblast function in the healing wound. Adv. Wound. Care (New Rochelle). 5: 119–136.

    Article  Google Scholar 

  8. Chen, M., T. Yan, K. Ma, L. Lai, C. Liu, L. Liang, and X. Fu (2016) Botulinum toxin type A inhibits alpha-smooth muscle actin and myosin II expression in fibroblasts derived from scar contracture. Ann. Plast. Surg. 77: e46–49.

    Article  CAS  Google Scholar 

  9. Liu, D. Q., X. J. Li, and Weng (2017) Effect of BTXA on inhibiting hypertrophic scar formation in a rabbit ear model. Aesthetic. Plast. Surg. 41: 721–728.

    Article  Google Scholar 

  10. Wang, H., Z. Chen, X. J. Li, L. Ma, and Y. L. Tang (2015) Anti-inflammatory cytokine TSG-6 inhibits hypertrophic scar formation in a rabbit ear model. Eur. J. Pharmacol. 751: 42–49.

    Article  CAS  Google Scholar 

  11. Phadke, C. P., A. Y. On, Y. Kirazli, F. Ismail, and C. Boulias (2013) Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper. Neurosci. Lett. 541: 20–23.

    Article  CAS  Google Scholar 

  12. Lee, B. J., J. H. Jeong, S. G. Wang, J. C. Lee, E. K. Goh, and H. W. Kim (2009) Effect of botulinum toxin type a on a rat surgical wound model. Clin. Exp. Otorhinolaryngol. 2: 20–27.

    Article  Google Scholar 

  13. Prodromidou, A., M. Frountzas, D. E. G. Vlachos, G. D. Vlachos, I. Bakoyiannis, D. Perrea, and V. Pergialiotis (2015) Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature. Plast. Surg (Oakv). 23: 260–264.

    Article  Google Scholar 

  14. Gassner, H. G., A. E. Brissett, C. C. Otley, D. K. Boahene, A. J. Boggust, A. L. Weaver, and D. A. Sherris (2006) Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study. Mayo. Clin. Proc. 81: 1023–1028.

    Article  CAS  Google Scholar 

  15. Xiao, Z. and G. Qu (2012) Effects of botulinum toxin type a on collagen deposition in hypertrophic scars. Molecules. 17: 2169–2177.

    Article  CAS  Google Scholar 

  16. Xiao, Z., F. Zhang, W. Lin, M. Zhang, and Y. Liu (2010) Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report. Aesthetic. Plast. Surg. 34: 424–427.

    Article  Google Scholar 

  17. Tanaka, J., T. Watanabe, N. Nakamura, and K. Sobue (1993) Morphological and biochemical analyses of contractile proteins (actin, myosin, caldesmon and tropomyosin) in normal and transformed cells. J. Cell. Sci. 104: 595–606.

    Article  CAS  Google Scholar 

  18. Bond, J. E., T. Q. Ho, M. A. Selim, C. L. Hunter, E. V. Bowers, and H. Levinson (2011) Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling. Lab. Invest. 91: 499–508.

    Article  CAS  Google Scholar 

  19. Vicente-Manzanares, M., X. Ma, R. S. Adelstein, and A. R. Horwitz (2009) Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell. Biol. 10: 778–790.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was funded by Anhui Science and Technology Research Project (1604a0802078)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiao-Jing Li.

Additional information

Disclosure Statement

The authors declare no conflicts of interest. This study was approved by the Animal Ethics Committee of Anhui Medical University (LLSC20170427) and no informed consent was required for this study.

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Liu, D., Li, X. et al. BTXA Could Induce Fibroblast Apoptosis and Inhibit the Expression of α-SMA and Myosin II in Scar Tissue of Rabbit Ears. Biotechnol Bioproc E 25, 699–706 (2020). https://doi.org/10.1007/s12257-019-0431-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12257-019-0431-9

Keywords

Navigation